4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-054455
Chief Executive Officer sold 7,800 shares at an average $40.22 ($313,753)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-10-04 | Sale | −2,600 | $40.09 | $104,234 | 56,078 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-10-04 | Sale | −1,300 | $41.34 | $53,742 | 54,778 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-10-05 | Sale | −1,900 | $39.58 | $75,202 | 52,878 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-10-05 | Sale | −1,900 | $40.25 | $76,475 | 50,978 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-10-05 | Sale | −100 | $41.00 | $4,100 | 50,878 | I |
| Open-market sales · 7,800 sh · avg $40.22 · $313,753 | |||||||
Loading xslF345X03/doc4.xml…